Showing 1 - 10 of 149
We estimate the impact of diabetic drug adherence on hospitalizations, ER visits, and hospital costs, using insurance claims from MarketScan® employer data. However, it is often difficult to measure the impact of drug adherence on hospitalizations since both adherence and hospitalizations may...
Persistent link: https://www.econbiz.de/10008631695
Persistent link: https://www.econbiz.de/10008383334
We estimate the impact of diabetic drug adherence on hospitalizations, ER visits, and hospital costs, using insurance claims from MarketScan® employer data. However, it is often difficult to measure the impact of drug adherence on hospitalizations since both adherence and hospitalizations may...
Persistent link: https://www.econbiz.de/10013148386
"The NBER Bulletin on Aging and Health provides summaries of publications like this. You can sign up to receive the NBER Bulletin on Aging and Health by email. We estimate the impact of diabetic drug adherence on hospitalizations, ER visits, and hospital costs, using insurance claims from...
Persistent link: https://www.econbiz.de/10003933934
Persistent link: https://www.econbiz.de/10008648677
We estimate the impact of diabetic drug adherence on hospitalizations, ER visits, and hospital costs, using insurance claims from MarketScan® employer data. However, it is often difficult to measure the impact of drug adherence on hospitalizations since both adherence and hospitalizations may...
Persistent link: https://www.econbiz.de/10012462961
Persistent link: https://www.econbiz.de/10012881746
Persistent link: https://www.econbiz.de/10013168277
Purpose – To estimate the impact of diabetic drug adherence on hospitalizations, emergency room (ER) visits, and hospital costs. Methods – It is often difficult to measure the impact of drug adherence on hospitalizations since both adherence and hospitalizations may be correlated with...
Persistent link: https://www.econbiz.de/10015381444
Persistent link: https://www.econbiz.de/10012282762